The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures

Lumbar Puncture Clinical Trial

— IQ-LP-03  

Official title:

The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04070144
• Other study ID #: IQ-LP-03
• Status: Completed
• Phase: N/A
• Start date: November 8, 2019
• Est. completion date: October 2, 2020

Study information

• Verified date: June 2023
• Source: Injeq Ltd
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures.

Description:

The primary purpose of the investigation is to demonstrate the claimed clinical benefit and safety of Injeq IQ-Tip™ system. IQ-Tip™ is similar to common spinal needles with a custom-made stylet that enables the real-time bioimpedance measurement at the tip of the needle. The needle is connected to the analyzer device, which provides real-time CSF detection during lumbar puncture from the very tip of the needle and by these means assists conducting the medical procedure. The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures. The investigation is conducted in the pediatric hematology and oncology units of three Finnish university hospitals

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 2, 2020
• Est. primary completion date: August 6, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Months to 18 Years

Eligibility

Inclusion Criteria:

• Pediatric hemato-oncology patients whose diagnosis or treatment plan requires lumbar puncture to acquire a CSF sample or to inject drug or other substance
• Written and signed informed consent before the procedure from the parent and/or patient depending on the age of the patient

Exclusion Criteria:

• Parents and/or patient refusal to participate or parents and/or patient unable to give informed consent
• Any contraindications to a lumbar puncture. Contraindications include skin infection around the puncture area, unstable hemodynamics, bleeding tendency and increased intracranial pressure

Related Conditions & MeSH terms

• Lumbar Puncture
• Wounds and Injuries

Intervention

Device:
• IQ-Tip(tm) system
Physician performs therapeutic or diagnostic lumbar puncture using Injeq IQ-Tip(tm) system

Locations

Country	Name	City	State
Finland	Helsinki University Hospital, New Children's Hospital	Helsinki
Finland	Tampere University Hospital	Tampere
Finland	Turku University Hospital	Turku

Sponsors (1)

Lead Sponsor	Collaborator
Injeq Ltd

Country where clinical trial is conducted

Finland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The First Puncture Success Rate	Each individual lumbar puncture procedure is assessed as either 'first puncture success' or '-failure'.; Success rate = Successes / All procedures; Definition of the first puncture success: Only one skin puncture with the needle is allowed; Multiple stylet removals and reinsertions are allowed; Multiple needle reorientations are allowed as long as needle tip remains inside the skin; Physician must be able obtain a cerebrospinal fluid (CSF) sample that is sent to a laboratory analysis or to inject the intended medication to the patient's subarachnoid space; and; Physician conducting the puncture remains the same during the procedure	The assessment immediately following each lumbar puncture procedure
Primary	Rate of Serious Adverse Events	Total number of serious adverse events caused by the device. Serious adverse event in probable or causal relationship to the investigational device exposure	The assessment during four-week follow-up after each lumbar puncture procedure
Secondary	Percentage of Procedures With Post-dural Puncture Headache (PDPH)	PDPH defined as headache that: worsens in sitting or standing position; eases when lying down; occurs within 7 days after the lumbar puncture procedure; Possible symptoms are recording using a diary filled by the patient or parents and verified by the study nurse.	The assessment during 7-day follow-up after each lumbar puncture procedure
Secondary	Percentage of CSF Samples With Greater or Equal to 10 Erythrocytes / mm^3	Erythrocyte (red blood cell) count according to laboratory analysis in units of 10^6/liter or 1/mm3	The laboratory analysis within 3 hours of the lumbar puncture
Secondary	Percentage of Procedures With Other Complications or Adverse Events	E.g. PDPH or backache; Possible symptoms are recorded using a diary filled by the patient or parents and verified by the study nurse. Diary is an open questionaire that is intended for recording any possible complication. Possible complications are not considered as pre-determined outcome measures, with the exception of Outcome #3 (rate of PDPH); Four-week follow up conducted by the study nurse from the hospital registers	The assessment during 7-day and four-week follow ups
Secondary	Aggregate Sensitivity of CSF Detection	The CSF detection performance of the investigational device is assessed by the physician.; Each individual lumbar puncture procedure is classified as either 'True Positive CSF detection (TP)', 'False Negative CSF detection (FN)' or 'Procedure failed (Fail)' by the investigator.; The aggregate sensitivity = Number of TPs / Total number of procedures	The assessment immediately following each lumbar puncture procedure
Secondary	Aggregate False Detection Rate of CSF Detection	Each individual lumbar puncture procedure is classified as either 'One or more False Positive CSF detections (FP)' or 'No False Positive CSF detections (TN)'.; The aggregate false detection rate = Number of FPs / Total number of procedures	The assessment immediately following each lumbar puncture procedure
Secondary	Number of Required Attempts Per Successful Lumbar Puncture Procedure	In line with definition of 'the first puncture success rate', attempt is defined as: any new penetration of skin is considered a new attempt.; Lumbar puncture is considered successful irrespective of the number of punctures if the CSF sample was eventually obtained and/or the injection of medicine could be performed	The assessment immediately following each lumbar puncture procedure
Secondary	Number of Failed Lumbar Puncture Procedures	Procedure is considered failed if physicians, even after multiple attempts, conclude that the lumbar puncture cannot be completed with available personnel or equipment due to any reason	The assessment immediately following each lumbar puncture procedure